Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zacary P Germon

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
International Journal of Molecular Sciences|December 5, 2019
The Role of Reactive Oxygen Species in Acute Myeloid LeukaemiaJonathan R Sillar, Zacary P Germon, Geoffry N DeIuliis, et al.
Trends in Cancer|March 11, 2026
The redox paradox in HGGs: ROS as drivers and destroyersPooja Kumari, Zacary P Germon, Evangeline R Jackson, et al.
Antioxidants (Basel, Switzerland)|October 23, 2021
Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine ResponsesAbdul Mannan, Zacary P Germon, Janis Chamberlain, et al.
Clinical Epigenetics|September 13, 2023
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemiaSam Humphries, Danielle R Bond, Zacary P Germon, et al.
Research Square|May 19, 2025
Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade GliomasRyan J Duchatel, Clara Savary, Zacary P Germon, et al.
Neuro-Oncology|February 2, 2026
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomasRyan J Duchatel, Clara Savary, Zacary P Germon, et al.
Molecular Cancer Research : MCR|September 27, 2022
B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric CancersTabitha McLachlan, William C Matthews, Evangeline R Jackson, et al.
Clinical Proteomics|December 19, 2022
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selectionDilana E Staudt, Heather C Murray, David A Skerrett-Byrne, et al.
Neuro-Oncology Advances|January 6, 2022
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine gliomaRyan J Duchatel, Abdul Mannan, Ameha S Woldu, et al.
Science Signaling|March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapiesZacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
International Journal of Molecular Sciences|December 5, 2019
The Role of Reactive Oxygen Species in Acute Myeloid LeukaemiaJonathan R Sillar, Zacary P Germon, Geoffry N DeIuliis, et al.
Trends in Cancer|March 11, 2026
The redox paradox in HGGs: ROS as drivers and destroyersPooja Kumari, Zacary P Germon, Evangeline R Jackson, et al.
Antioxidants (Basel, Switzerland)|October 23, 2021
Reactive Oxygen Species in Acute Lymphoblastic Leukaemia: Reducing Radicals to Refine ResponsesAbdul Mannan, Zacary P Germon, Janis Chamberlain, et al.
Clinical Epigenetics|September 13, 2023
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemiaSam Humphries, Danielle R Bond, Zacary P Germon, et al.
Research Square|May 19, 2025
Beyond Base Camp: Promise and Pitfalls of PI3K/mTOR Inhibition in Pediatric High- Grade GliomasRyan J Duchatel, Clara Savary, Zacary P Germon, et al.
Neuro-Oncology|February 2, 2026
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomasRyan J Duchatel, Clara Savary, Zacary P Germon, et al.
Molecular Cancer Research : MCR|September 27, 2022
B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric CancersTabitha McLachlan, William C Matthews, Evangeline R Jackson, et al.
Clinical Proteomics|December 19, 2022
Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selectionDilana E Staudt, Heather C Murray, David A Skerrett-Byrne, et al.
Neuro-Oncology Advances|January 6, 2022
Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine gliomaRyan J Duchatel, Abdul Mannan, Ameha S Woldu, et al.
Science Signaling|March 28, 2023
Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapiesZacary P Germon, Jonathan R Sillar, Abdul Mannan, et al.
Pageof 2